Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
IF/TA, Interstitial fibrosis/tubular atrophy
& Surani, S
Dosing frequency must account for the pharmacokinetic clearance (how often you need to re-activate receptors) rather than the pharmacodynamic persistence (how long you see visible effects)
Javaid recommends that you: Document your cycle changes in detail (she says that healthcare providers typically recommend keeping a detailed menstrual diary including flow changes, cycle duration, pain and any associated symptoms) Contact your healthcare provider for evaluation Don't stop the medication without consulting your doctor Once youve notified your healthcare providers of any changes that might occur, they will likely take the following steps to determine if changes are related to the medication, weight loss or other factors
